Is there potential for using antibodies generated by people who have recovered from COVID-19 to prevent infection and treat those who are sick?
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Is there potential for using antibodies generated by people who have recovered from COVID-19 to prevent infection and treat those who are sick? Dr. Josh Sharfstein talks to Arturo Casadevall, chair of Department of Molecular Microbiology and Immunology at the Bloomberg School of Public Health, about a landmark 1934 case where antibodies helped stopped a measles outbreak.
Published March 17, 2020
Is there potential for using antibodies generated by people who have recovered from COVID-19 to prevent infection and treat those who are sick? Dr. Josh Sharfstein talks to Arturo Casadevall, chair of Department of Molecular Microbiology and Immunology at the Bloomberg School of Public Health, about a landmark 1934 case where antibodies helped stopped a measles outbreak.
Published March 17, 2020
Phase 3 study results of plozasiran in patients with FCS
FCS and SHTG: Are We Meeting the Need?
Evolutions in Duchenne Muscular Dystrophy: Treatment Implications for the Present and Future
IgG4-RD Case Conversations: Using Thoracic CT as a Diagnostic Clue
Digesting IgG4-RD: An Interactive, Multidisciplinary Case Conference
Episode 2 Part B: Effectively Transferring Over the CKD Patient at the Right Time
HF Management for Patients with Comorbid Conditions
Level Up Your Skills: Tailoring Management of HF
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?
Stay current with the best on medical education
